How do you approach a patient with a non-castrate testosterone level and rising PSA despite receiving LHRH agonist therapy?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Colorado Denver
Answered on
This is a good question. It is always good to check on the testosterone value in men on LHRH agonist therapy in order to ensure the level truly is within castrate range. I assume this patient has been on therapy for a number of months (i.e. the testosterone has had time for full suppression). If so,...
Join for free or sign in to see the full answer